MedPath

Ranitidine

Generic Name
Ranitidine
Brand Names
Good Sense Acid Reducer, Wal-zan, Zantac
Drug Type
Small Molecule
Chemical Formula
C13H22N4O3S
CAS Number
66357-35-5
Unique Ingredient Identifier
884KT10YB7

Overview

Ranitidine is a commonly used drug, classified as a histamine H2-receptor antagonist, and belongs to the same drug class as cimetidine and famotidine. This drug helps to prevent and treat gastric-acid associated conditions, including ulcers, because of its ability to decrease gastric acid secretion. Ranitidine is often referred to as Zantac, and is available in various forms, including tablet, injection, and effervescent tablet preparations. The prevalence of GERD is thought to be 10-20% in western countries. Ranitidine has proven to be an effective treatment for relieving uncomfortable symptoms of gastric acid associated conditions and is therefore widely used in GERD and other gastric-acid related conditions.

Background

Ranitidine is a commonly used drug, classified as a histamine H2-receptor antagonist, and belongs to the same drug class as cimetidine and famotidine. This drug helps to prevent and treat gastric-acid associated conditions, including ulcers, because of its ability to decrease gastric acid secretion. Ranitidine is often referred to as Zantac, and is available in various forms, including tablet, injection, and effervescent tablet preparations. The prevalence of GERD is thought to be 10-20% in western countries. Ranitidine has proven to be an effective treatment for relieving uncomfortable symptoms of gastric acid associated conditions and is therefore widely used in GERD and other gastric-acid related conditions.

Indication

This drug is used alone or with concomitant antacids for the following conditions: short-term treatment of active duodenal ulcer, treating gastric acid hypersecretion due to Zollinger-Ellison syndrome, systemic mastocytosis, and other conditions that may pathologically raise gastric acid levels. It also used in the short term treatment of active benign gastric ulcers and maintenance therapy of gastric ulcers at a reduced dose. In addition to the above, ranitidine can be used for the treatment of GERD symptoms, treatment of erosive esophagitis (endoscopically diagnosed) and the maintenance of gastric or duodenal ulcer healing.

Associated Conditions

  • Acid Aspiration Syndrome
  • Ankylosing Spondylitis (AS)
  • Duodenal Ulcer
  • Erosive Esophagitis
  • Gastric Ulcer
  • Gastric hypersecretion
  • Gastro-esophageal Reflux Disease (GERD)
  • Healing
  • Heartburn
  • Osteoarthritis (OA)
  • Peptic Ulcer Disease
  • Rheumatoid Arthritis
  • Stress Ulcers
  • Zollinger-Ellison Syndrome
  • Active Duodenal ulcer
  • Benign gastric ulcer healing
  • Benign gastric ulcers
  • Duodenal ulcer healing
  • Post-operative peptic ulcer
  • Recurrent hemorrhage from bleeding ulcers

FDA Approved Products

Ranitidine Immediate release
Manufacturer:Aphena Pharma Solutions - Tennessee, LLC
Route:ORAL
Strength:150 mg in 1 1
Approved: 2019/11/19
NDC:71610-359
RANITIDINE
Manufacturer:STAT Rx USA LLC
Route:ORAL
Strength:300 mg in 1 1
Approved: 2012/10/03
NDC:16590-381
Ranitidine
Manufacturer:Pharmaceutical Associates, Inc.
Route:ORAL
Strength:15 mg in 1 mL
Approved: 2022/01/12
NDC:0121-4727
Ranitidine
Manufacturer:Bryant Ranch Prepack
Route:ORAL
Strength:150 mg in 1 1
Approved: 2018/12/07
NDC:71335-1327
Ranitidine Hydrochloride
Manufacturer:State of Florida DOH Central Pharmacy
Route:ORAL
Strength:150 mg in 1 1
Approved: 2010/04/13
NDC:53808-0776

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath